Found: 147
Select item for more details and to access through your institution.
Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States' National Vital Statistics System.
- Published in:
- PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0289202
- By:
- Publication type:
- Article
Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: Data from Hong Kong.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1024, doi. 10.1111/hepr.13535
- By:
- Publication type:
- Article
Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality.
- Published in:
- Clinical Diabetes, 2019, v. 37, n. 1, p. 65, doi. 10.2337/cd18-0026
- By:
- Publication type:
- Article
Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States.
- Published in:
- Clinical Diabetes, 2017, v. 35, n. 2, p. 79, doi. 10.2337/cd16-0018
- By:
- Publication type:
- Article
Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204772
- By:
- Publication type:
- Article
Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2018, v. 11, p. 1, doi. 10.1177/1756284818811508
- By:
- Publication type:
- Article
The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment.
- Published in:
- Therapeutic Advances in Gastroenterology, 2015, v. 8, n. 5, p. 298, doi. 10.1177/1756283X15587481
- By:
- Publication type:
- Article
Review: Treatment options for nonalcoholic fatty liver disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2010, v. 3, n. 2, p. 121, doi. 10.1177/1756283X09359964
- By:
- Publication type:
- Article
Reply to Bailly et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 6, p. 1063, doi. 10.1093/cid/ciab579
- By:
- Publication type:
- Article
Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 4, p. 628, doi. 10.1093/cid/ciz243
- By:
- Publication type:
- Article
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 11, p. 1742, doi. 10.1093/cid/cix1106
- By:
- Publication type:
- Article
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Trends in Liver Transplantation in Hepatitis C Virus-Infected Persons, United States.
- Published in:
- 2016
- By:
- Publication type:
- letter
Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system.
- Published in:
- PLoS ONE, 2022, v. 18, n. 2, p. 1, doi. 10.1371/journal.pone.0263417
- By:
- Publication type:
- Article
Ribavirin-Free RegimenWith Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 8, p. 1042, doi. 10.1093/cid/ciw496
- By:
- Publication type:
- Article
215-LB: Diabetes and Obesity Are the Main Drivers of Increasing Chronic Liver Disease in the United States (U.S.) in the Past Three Decades.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-215-LB
- By:
- Publication type:
- Article
The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07657-z
- By:
- Publication type:
- Article
Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa.
- Published in:
- Liver International, 2024, v. 44, n. 4, p. 1061, doi. 10.1111/liv.15852
- By:
- Publication type:
- Article
The impact of fatigue on mortality of patients with non‐alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005–2010 and 2017–2018.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2646, doi. 10.1111/liv.15437
- By:
- Publication type:
- Article
Increased cancer rates in patients with chronic hepatitis C.
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 685, doi. 10.1111/liv.14305
- By:
- Publication type:
- Article
Hypothetical treatment of patients with non‐alcoholic steatohepatitis: Potential impact on important clinical outcomes.
- Published in:
- Liver International, 2020, v. 40, n. 2, p. 308, doi. 10.1111/liv.14292
- By:
- Publication type:
- Article
Patient‐reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication.
- Published in:
- Liver International, 2019, v. 39, n. 10, p. 1837, doi. 10.1111/liv.14171
- By:
- Publication type:
- Article
Trends in hospitalizations for chronic liver disease‐related liver failure in the United States, 2005‐2014.
- Published in:
- Liver International, 2019, v. 39, n. 9, p. 1661, doi. 10.1111/liv.14135
- By:
- Publication type:
- Article
Cytokine balance is restored as patient‐reported outcomes improve in patients recovering from chronic hepatitis C.
- Published in:
- Liver International, 2019, v. 39, n. 9, p. 1631, doi. 10.1111/liv.14115
- By:
- Publication type:
- Article
Prevalence and outcomes of non‐alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States.
- Published in:
- Liver International, 2019, v. 39, n. 4, p. 748, doi. 10.1111/liv.14038
- By:
- Publication type:
- Article
Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2019, v. 39, n. 2, p. 342, doi. 10.1111/liv.13992
- By:
- Publication type:
- Article
Predictors of nonalcoholic steatohepatitis and significant fibrosis in non‐obese nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2019, v. 39, n. 2, p. 332, doi. 10.1111/liv.13983
- By:
- Publication type:
- Article
Viral eradication is required for sustained improvement of patient‐reported outcomes in patients with hepatitis C.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 54, doi. 10.1111/liv.13900
- By:
- Publication type:
- Article
Improvement of hepatic fibrosis and patient‐reported outcomes in non‐alcoholic steatohepatitis treated with selonsertib.
- Published in:
- Liver International, 2018, v. 38, n. 10, p. 1849, doi. 10.1111/liv.13706
- By:
- Publication type:
- Article
Response to the letter: Hepatitis C screening in opioid epidemics in the United States and societal perspectives.
- Published in:
- Liver International, 2018, v. 38, n. 7, p. 1331, doi. 10.1111/liv.13891
- By:
- Publication type:
- Article
Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.
- Published in:
- Liver International, 2017, v. 37, n. 12, p. 1796, doi. 10.1111/liv.13462
- By:
- Publication type:
- Article
A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ- NAFLD.
- Published in:
- Liver International, 2017, v. 37, n. 8, p. 1209, doi. 10.1111/liv.13391
- By:
- Publication type:
- Article
The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society?
- Published in:
- Liver International, 2017, v. 37, n. 5, p. 662, doi. 10.1111/liv.13298
- By:
- Publication type:
- Article
The impact of hepatitis C virus outside the liver: Evidence from Asia.
- Published in:
- Liver International, 2017, v. 37, n. 2, p. 159, doi. 10.1111/liv.13272
- By:
- Publication type:
- Article
Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?
- Published in:
- Liver International, 2016, v. 36, n. 8, p. 1096, doi. 10.1111/liv.13164
- By:
- Publication type:
- Article
Sympotomatic porphyria cutanea tarda and B-immunoblastic lymphoma: Is there an association?
- Published in:
- American Journal of Hematology, 1996, v. 51, n. 3, p. 252, doi. 10.1002/(SICI)1096-8652(199603)51:3<252::AID-AJH21>3.0.CO;2-H
- By:
- Publication type:
- Article
Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006–2016.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1093/ofid/ofz509
- By:
- Publication type:
- Article
Association of Serum Adipocytokines with Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C.
- Published in:
- Digestion, 2010, v. 83, n. 1/2, p. 32, doi. 10.1159/000314592
- By:
- Publication type:
- Article
A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis.
- Published in:
- Obesity Surgery, 2011, v. 21, n. 4, p. 431, doi. 10.1007/s11695-010-0204-1
- By:
- Publication type:
- Article
Nutritional Assessments of Patients with Non-alcoholic Fatty Liver Disease.
- Published in:
- Obesity Surgery, 2010, v. 20, n. 2, p. 154, doi. 10.1007/s11695-008-9549-0
- By:
- Publication type:
- Article
Hepatic stellate cell and myofibroblast-like cell gene expression in the explanted cirrhotic livers of patients undergoing liver transplantation.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Demonstration of two types of fatigue in subjects with chronic liver disease using factor analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The factorial structure of the Chronic Liver Disease Questionnaire (CLDQ).
- Published in:
- Quality of Life Research, 2008, v. 17, n. 4, p. 575, doi. 10.1007/s11136-008-9332-7
- By:
- Publication type:
- Article
Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 6, p. 300, doi. 10.1111/jvh.13935
- By:
- Publication type:
- Article
The impact of hepatitis B and C positive serologies on the outcomes of non‐hepatic solid organ transplantation in the United States.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 4, p. 181, doi. 10.1111/jvh.13916
- By:
- Publication type:
- Article
Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 4, p. 335, doi. 10.1111/jvh.13800
- By:
- Publication type:
- Article